Additional Insights on Metabolically Healthy Obesity Among Pediatric Populations

By
Taotao Zheng
Yan He
Ke Pan
September 1, 2026

Jama Pediatrics

Background

Childhood obesity is a significant global health concern, with rising prevalence rates. Understanding the long-term outcomes of children with metabolically healthy obesity is crucial, as they may still face elevated risks for cardiometabolic diseases.

Data Highlights

Outcome	MHO Group (%)	General Population (%)
Type 2 Diabetes	9.1	0.5
Hypertension	10.8	3.7
Dyslipidemia	5.3	0.9

Key Findings

Cumulative incidence of type 2 diabetes in the MHO group was 9.1% by age 30 years.
Type 2 diabetes incidence in the MHO group was significantly higher than in the general population (0.5%).
Participants in the MHO group had a hypertension incidence of 10.8%, compared to 3.7% in the general population.
Dyslipidemia was observed in 5.3% of the MHO group versus 0.9% in the general population.
The study lacked a comparator group of untreated children with MHO, limiting the interpretation of treatment effects.
Psychosocial harms associated with weight loss interventions were not analyzed in the study.

Clinical Implications

Healthcare professionals should consider the long-term cardiometabolic risks associated with metabolically healthy obesity when evaluating treatment options. Additionally, the potential psychological impacts of weight management interventions should be factored into clinical decision-making.

Conclusion

The findings emphasize the need for a nuanced approach to treating pediatric obesity, particularly for those classified as metabolically healthy, while also addressing the psychological aspects of treatment.